Thanks for the link; That has to be one of the best post I have ever read(and can understand)!! Since that post(12/15/2009) many good things has happened. Not just money,but strength in management("Robert M. Whelan, Jr., a highly regarded financial and business advisor"),Orphan Drug Designation("ARIAD Receives Orphan Drug Designations for Its Investigational pan BCR-ABL Inhibitor, AP24534, in Chronic Myeloid Leukemia") Copy of the link you provided= http://siliconinvestor.advfn.com/readmsg.aspx?msgid=26178369
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.